LSO Annual Policy Forum

Friday, December 01, 2017


2017 Annual Life Sciences Policy Forum  


Elevating Life Sciences to the Top of the Political Agenda 

 December 1st, 2017, 8am-5pm
Borden Ladner Gervais LLP, Toronto


Click here to view the program


On December 1, 2017, LSO will host its Annual Policy Forum, where life sciences leaders and senior government officials will discuss how we can move our sector to the top of the political agenda, positioning it for global success.  

Less than one year from a provincial election, how does life sciences factor in to each party’s policy objectives? What is their vision for life sciences and what initiatives will they put in place to support Ontario’s largest growth opportunity? Register for this must-attend event to help shape Ontario life sciences policy for 2018 and beyond.


Click here to register for the Forum
(having trouble opening the registration link, click here to update your browser)


André Picard, Health Columnist, The Globe and Mail
André Picard is the health columnist at The Globe and Mail and the author of five books, including Matters of Life and Death: Public Health Issues in Canada, and The Path to Health Care Reform: Policies and Politics.
André has received much acclaim for his writing, including the Michener Award for Meritorious Public Service Journalism and the Centennial Prize of the Pan-American Health Association, awarded to the top health journalist in the Americas.  He is also an eight-time finalist for the National Newspaper Awards – Canada’s version of the Pulitzer Prize.
He is a seasoned communicator who employs a conversational style to reach his audience. He enlivens his research and commentary with personal stories to provide context for his audience, including anecdotes from patients and health professionals the front lines.
André will enlighten and peak a sense of curiosity of audience members from all educational backgrounds. His work as one of North America’s top health journalists reflects his personality: Behind the placid exterior lies an inquisitive, perceptive and industrious scribe for whom the work only begins with the official story.
André is a graduate of the University of Ottawa and Carleton University, and has received honourary doctorates from six universities, including the University of Toronto, UBC and the University of Manitoba.

Confirmed Speakers:

  • Allison Barr, Director, Office of the Chief Scientist
  • Alok Kanti, President & CEO, Bayer
  • André Picard, Health Columnist, The Globe and Mail
  • Carly Martin, Director of Stakeholder Outreach, eSight
  • Chris Walker, Principal, HarbourVest
  • Greg Wootton, Assistant Deputy Minister, Ministry of Economic Development and Growth
  • Har Grover, Chairman & CEO, Scientus Pharma
  • Ian Stedman, Board Member, Canadian Organization for Rare Disorders
  • John Marshall, Assistant Deputy Minister, Ministry of Economic Development and Growth
  • Mark Smithyes, Chair, Life Sciences Ontario; President, Labtician Théa
  • Maurice Bitran, CEO & Chief Science Officer, Ontario Science Centre
  • Michael J. Kousaie, Head of Business Development, Technology, Toronto Stock Exchange and TSX Venture Exchange
  • Paul Manias, Managing Director, OMERS Platform Investments
  • Ryan Cook, Business Advisor, Investor, Co-founder, DNAstack
  • Ryan Wiley, President, Shift Health
  • Sabina Steinkellner, Chief Commercial Officer, Sanofi Pasteur Limited  
  • Serge Marchand, Scientific Director, Fonds de recherche du Québec – Santé (FRQS)
  • Shermaine Tilley, Managing Partner, CTI Life Sciences Fund
  • Will Rowe, President, CEO and Co-Founder, Nutrasource Diagnostics  


Panel Session Topics Include:

Provincial Life Sciences Policy: 2018 and Beyond Panel
Regardless of the outcome of the next Provincial election, the Ontario Public Service will continue to work toward growing Ontario’s life sciences sector. What are the key priorities for the OPS leading up to the election and how do these align with the LSO BluePrint presented?
Access to Capital: Strategies to Fuel Innovation and Economic Growth Panel
Access to capital has been repeatedly singled out as a significant barrier to innovation and the success of Ontario life sciences companies. What immediate and long-term strategies are needed to ensure we create and retain made-in-Ontario success stories?  How can government and the private sector work together productively to tackle this challenge?
Federal and Provincial Science Policy Landscape
As both Provincial and Federal Governments hire Chief Scientists, these new roles have the potential to influence key policy items across government – from support for innovation, rare diseases, NAFTA negotiations and hot-button issues surrounding Trump and the pharmaceutical industry. What should the role and scope of these positions be, and what impacts can we expect for our life sciences and innovation ecosystem?
The Business of Policy
From start-ups to multinationals, governments play an important role in creating a competitive business environment for Ontario life sciences companies in terms of Procurement, Access to Capital, Talent and Investment Attraction. How does public policy influence life sciences companies of different types across our industry? How can government and the private sector effectively work together to the benefit of our sector as a whole?

Sponsorship Opportunities:

There are some sponsorship opportunities available. Click here to see more details.


Borden Ladner Gervais
Bay Adelaide Centre, E. Tower,
22 Adelaide St W.,
Toronto, ON M5H 4E3